Friday, December 4, from 1pm to 4pm ET

Registration for the 2020 ALS TDI Summit has closed. The Summit will be recorded and the video will be available for viewing following the event.

The ALS TDI Summit is a free conference that aims to inform and empower the ALS community by educating attendees about ALS TDI's latest work to discover and develop effective treatments for ALS. Led by scientists from the ALS Therapy Development Institute, the Summit invites all members of the community to come and learn about ALS TDI's cutting-edge approach to ending ALS.

The 2020 ALS TDI Summit will include research updates from ALS TDI Chief Scientific Officer, Fernando Vieira, M.D. and Director of Pharmacology, Theo Hatzipetros Ph.D. In addition, this year the Summit will include a guest presentation titled, ALS Reversals: What We Know So Far and What Comes Next, from Dr. Richard Bedlack, Director & Neurologist at the Duke ALS Clinic.

2020 Summit Overview

1:00pm - Welcome and Agenda: Jon Gang | Communications Manager at ALS TDI

1:15pm - Pharmacology in the Time of COVID-19: Theo Hatzipetros, Ph.D. | Director of Pharmacology at ALS TDI

1:50pm - ALS Reversals: What we know so far and what comes next: Richard Bedlack, M.D., Ph.D., M.S. | Director and Neurologist at Duke ALS Clinic

2:45pm - ALS TDI Research Update and Outlook: Fernando Vieira, M.D. | Chief Scientific Officer at ALS TDI

3:30pm - Closing Remarks: Steve Perrin, Ph.D. | Chief Executive Officer at ALS TDI

3:40pm - ALS TDI Leadership Awards: Presented by Carol Hamilton | Sr. Director of Development at ALS TDI

Who Should Attend?

The ALS TDI Summit is free and is open to all members of the ALS community, including:

• people with ALS
• caregivers
• friends and family members
• members of the ALS research and science community

To learn more about research at ALS TDI, visit www.als.net/als-research/.

Thank you to our sponsors: